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Available online 21 September 2016Knowledge of how an in vitro aerosol exposure system delivers a test aerosols to the biological test system is
among themost crucial prerequisites for the interpretation of exposure experiments and relies on detailed expo-
sure system characterization. Although various methods for this purpose exist, many of them are time consum-
ing, require extensive instrumentation, or offer only limited ability to assess the performance of the systemunder
experimental settings. We present the development and evaluation of a new, highly robust and sensitive ﬂuo-
rometry-based method for assessing the particle size speciﬁc delivery of liquid aerosols.
Glycerol aerosols of different mean particle sizes and narrow size distributions, carrying the ﬂuorophore
disodium ﬂuorescein, were generated in a condensation monodisperse aerosol generator. Their detailed charac-
terization conﬁrmed their stability and the robustness and reproducibility of their generation. Test exposures
under relevant experimental settings in the Vitrocell® 24/48 aerosol exposure system further conﬁrmed their
feasibility for simulating exposures and the high sensitivity of the method.
Potential applications of the presented method range from the experimental conﬁrmation of computationally
simulated particle dynamics, over the characterization of in vitro aerosol exposure systems, to the detailed de-
scription of aerosol delivery in test systems of high complexity.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Vitrocell1. Introduction
With the wide commercialization of electronic cigarettes (e-ciga-
rettes), there is a growing interest in evaluating the toxicity of the aero-
sols they generate (Farsalinos & Polosa, 2014; Riker et al., 2012; Pepper
& Eissenberg, 2014; Pisinger & Døssing, 2014), which, in light of at-
tempts to reduce animal experimentation, is projected to involve
more and more in vitro toxicological studies. However, in vitro toxico-
logical assessment of aerosols is technically challenging. It is generally
accepted that exposing submersed cell cultures to extracts of aerosols
trapped on ﬁlters or in solvents cannot, or can only to a very limited ex-
tent, simulate the interaction between a native aerosol and the epithe-
lial lining of the respiratory tract, as the collection and processing of a
test aerosol inevitably results in changes to its physicochemical proper-
ties. In addition, it is well established that the submersed state of cell
cultures is not representative of conditions in the respiratory tractrosol generator; DSF, disodium
sure system; PBS, phosphate
por phase; APS, aerodynamic
metric standard deviation; CFP,
, upper limit of quantiﬁcation;
. This is an open access article under(Paur et al., 2008; Panas et al., 2014; Hirsch et al., 2013; Paur et al.,
2011; BéruBé et al., 2010).
In consequence, aerosol exposure at the air-liquid interface (ALI) is
the preferable approach. This method requires the test aerosols to be
conditioned to meet speciﬁc requirements of the cell cultures in terms
of temperature and humidity, and to be diluted to achieve realistic
doses and dose responses (Paur et al., 2008; Grass et al., 2010). This is
commonly achieved in aerosol exposure systems, several of which
have been developed in the past years (Paur et al., 2008; Thorne &
Adamson, 2013). However, whereas their working principles may
vary greatly, they share the common property that besides adjusting
the relative humidity, temperature and concentration, they potentially
also change other aerosol characteristics. This includes, for instance,
the particle number-size distribution (Alonso et al., 1999), the total par-
ticlemass (Chang et al., 1985) and thepartitioning of semi-volatile com-
pounds between particulate matter (PM) and the gas-vapor phase
(GVP) (Chang et al., 1985). As the delivery efﬁciencies of GVP, PM and
particles of different sizes must be assumed to not be equal (Fujitani
et al., 2015; Ishikawa et al., 2016; Guha, 2008; Sahu et al., 2013), this in-
evitably inﬂuences the aerosol delivery to the biological test system.
Predictions of dosing from the physicochemical properties of the origi-
nal aerosol are therefore highly error-prone, and affect the relevance
of in vitro studies that require the achieved aerosol delivery to be
known, and moreover, to be representative for the targeted region ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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a fully reproducible performance of the exposure systems cannot be as-
sumed by implication and in the case of systems that allow exposing
multiple cell cultures simultaneously—be it as replicates or for testing
serially diluted aerosols (or both)—inaccurate dosing and/or non-uni-
form aerosol delivery may occur (Adamson et al., 2014).
Literature is available on howvarious aerosols, including smoke gen-
erated by conventional cigarettes, are delivered in in vitro exposure sys-
tems (Fujitani et al., 2015; Ishikawa et al., 2016; Adamson et al., 2014;
Majeed et al., 2014; Kaur et al., 2010; Adamson et al., 2012;
Asimakopoulou et al., 2011; Aufderheide et al., 2013; Kim et al., 2013;
Scian et al., 2009; Tippe et al., 2002; Wiegand et al., 2015; Fröhlich et
al., 2013;Mertes et al., 2013), but only a limited number of these studies
focused on water-soluble, liquid aerosols containing low amounts of
volatile and semi-volatile compounds, such as those generated by vari-
ous e-cigarettes (Hajek et al., 2014). In many aspects, such aerosols be-
have differently than dry powders or combustion products (Koehler et
al., 2012; Feng et al., 2015; Marple et al., 1991; Lízal et al., 2010;
Mullins et al., 2003), and will as a result be delivered differently in in
vitro exposure systems. In particular, if a direct toxicological comparison
between whole smoke generated by conventional cigarettes and aero-
sols generated by e-cigarettes is attempted, great care must be taken
when establishing comparable doses. Identical or nearly identical proto-
cols for the generation and application of conventional cigarette smoke
and e-cigarette aerosol as applied in many studies (Cervellati et al.,
2014; Neilson et al., 2015; Schefﬂer et al., 2015; Shen et al., 2016) cannot
be assumed to result in comparable delivery, unless this was conﬁrmed
by quantiﬁcation of aerosol delivery to the exposure chambers or by de-
tailed exposure system characterization.
Exposure system characterization can be approached in two distinct
but not exclusive ways: By comparing the aerosol entering the system
(or a part of the system) with the aerosol leaving the system (or a
part thereof), or by direct quantiﬁcation of aerosol deposition on rele-
vant internal surfaces of the system. The former approach allows mea-
suring aerosol evolution and deposition on-line, even simultaneously
with the exposure of the biological test systems. It suffers, however,
from low spatial resolution, as the exact location within the system at
which the observed changes arise cannot be determined. Direct quanti-
ﬁcation of aerosol deposition, although it can be performed on-line
(Thorne & Adamson, 2013; Adamson et al., 2012; Wiegand et al.,
2015), is usually performed after exposure or in separate experiments
speciﬁcally dedicated to system characterization. Commonly applied
methodologies include for example counting deposited particles using
electron microscopy (Panas et al., 2014; Fujitani et al., 2015; Kim et al.,
2013; Tippe et al., 2002; Fröhlich et al., 2013), absorbance/colorimetric
measurements (Majeed et al., 2014; Scian et al., 2009), or chromato-
graphic procedures (Thorne & Adamson, 2013; Ishikawa et al., 2016;
Majeed et al., 2014; Mertes et al., 2013). These methods allow the de-
scription of aerosol delivery in an exposure system with an impressive
level of detail, and are clearly indispensable for describing the exact dos-
ing of complex multicomponent aerosols. The advantages notwith-
standing, these methods are usually time-consuming, expensive, and
require extensive analytical equipment and may therefore not be suit-
able for many institutions performing in vitro aerosol exposures. In ad-
dition, in many aspects it is advantageous to perform exposure system
characterization with model aerosols of low complexity, especially
when amechanistic understanding of the system and not only the aero-
sol delivery to the exposure chambers is of interest.
In this paper, we describe a method for the quantiﬁcation of aerosol
deposition that, because of its simple but robust character, allows char-
acterizing the aerosol delivery in an aerosol exposure system in detail
even if extensive analytical equipment is unavailable. We focused spe-
ciﬁcally on aerosols comparable to those generated by common types
of e-cigarettes, because for this kind of aerosols, only a limited number
of established methods for exposure system characterization are avail-
able. Since the aerosols generated by e-cigarettes (but also by variousmedical devices for drug inhalation) contain large amounts of glycerol
(Hajek et al., 2014; Watts et al., 2008; Patton & Byron, 2007; Haghi et
al., 2014), we chose glycerol as the aerosol material. Fluorometry was
used for aerosol detectionbecause of its robustness and simplicity in im-
plementation, disodium ﬂuorescein (DSF) was chosen as the ﬂuores-
cent label.
As a proof of concept, we applied themethod to the Vitrocell® 24/48
aerosol exposure system (VC24/48, VITROCELL Systems GmbH,
Waldkirch, Germany), the system we use at our facility for exposing
organotypic cell cultures as a part of the toxicological assessment of con-
ventional and novel tobacco products.We thereby focused on the sensi-
tivity of the method and on the dosing accuracy.
2. Materials and methods
2.1. Aerosol generation
Fluorescent aerosols were generated in a TSI 3475 condensation
monodisperse aerosol generator (CMAG) (TSI, Shoreview, MN, USA).
Its working principle relies on aerosolizing an aqueous salt solution in
an atomizer and drying the obtained aerosol in a diffusion dryer,
resulting in salt crystals of roughly 100-nm diameter. In a saturator,
these salt nuclei are bubbled through heated aerosol material and the
obtained nuclei-vapor mixture is subsequently heated in a re-heater
unit, where complete evaporation of the aerosol material is assured.
Cooling down in a condensation chimney causes super-saturation and
homogeneous condensation of the vapor onto the salt nuclei. By varying
the temperature in the saturator and the volume ﬂow through the sat-
urator, and by removing a part of the salt nuclei via ﬁltration, the
amount of aerosol material per salt nucleus, and thereby the resulting
particle size, can be modulated.
For our application, we used a 0.5% aqueous solution of DSF, (Sigma-
Aldrich, Munich, Germany) as the source of the salt nuclei, onto which
glycerol (N99.5%, Sigma Aldrich) as aerosol material was condensed.
The applied CMAG settings are listed in Table 1.
2.2. Aerosol characterization
Various aerosols of different particle number-size distributions
could be generated in the CMAG, four of which were selected for more
detailed characterization (Table 1).
In eight independent repetitions, particle number-size distributions
and their modes, mean aerodynamic particle sizes and their geometric
standard deviations (GSDs), and median aerodynamic particle sizes
were measured continuously during 20–25min, using a TSI 3321 Aero-
dynamic Particle Sizer (APS)with an accessory dilution unit (TSI 3302 A
Aerosol Diluter, 100:1 capillary inserted). The APSwas set to report data
averaged over 10 s, and the obtained 120–150 data points per repetition
were averaged for assessing intra- and inter-repetition stability of the
aerosol generation.
Particle concentrations were also measured, but as the APS was op-
erated at the upper limits of reliably measureable particle densities, the
reported values are expected to underestimate the actual concentra-
tions. Since in addition, the aerosol density was primarily captured by
the DSF and aerosol mass ﬂow rates, particle concentrations reported
by the APS are not further used as quantitative data.
To derive aerosol mass deliveries in an aerosol exposure system
based on ﬂuorometric quantiﬁcation of DSF delivery, the DSF and aero-
solmass ﬂow rates through the system during test exposures need to be
determined. This was achieved by trapping the aerosols on weighted
Cambridge ﬁlter pads (CFPs) (Borgwaldt KC, Hamburg, Germany) for
deﬁned periods of time (1–5 min, depending on the aerosol size)
followed by determination of the deposited aerosol mass and elution
and ﬂuorometric quantiﬁcation of the deposited DSF. To characterize
the four selected aerosols, this was done with the APS, but not the
VC24/48 being installed downstream of the CFP-holder. Trapping was
Table 1
Aerosol generation and characterization (N= 8).
Nominal mean aerodynamic particle diameter 0.8 μm 1.1 μm 1.4 μm 1.6 μm
CMAG settings
Total ﬂow (rotameter scale valuea) 8 8 8 8
Saturator ﬂow (rotameter scale valuea) 1.5–2 3.75–4.25 6.75–7.25 7.75–8
Screen ﬂow (rotameter scale valuea) 1 1 1 3.5–4.5
Saturator temperature (°C) 160 160 160 160
Reheated temperature (°C) 340 340 340 340
Aerosol characterization Average ± SD (CV) Average ± SD (CV) Average ± SD (CV) Average ± SD (CV)
Aerosol mass ﬂow rate (mg/min) 18.9 ± 1.8 (9.6) 42.8 ± 2.1 (5.0) 84.1 ± 3.9 (4.6) 93.0 ± 2.9 (3.2)
DSF mass ﬂow rate (mg/min) 0.102 ± 0.009 (9.1) 0.106 ± 0.021 (20.2) 0.096 ± 0.014 (14.6) 0.065 ± 0.003 (5.1)
Mass ratio DSF/Aerosol 0.0054 ± 0.0007 (12.5) 0.0025 ± 0.0005 (20.3) 0.0011 ± 0.0002 (16.4) 0.0007 ± 0.0000 (5.3)
Mean aerodynamic particle diameter (μm) 0.83 ± 0.02 (3.0) 1.13 ± 0.03 (3.1) 1.41 ± 0.02 (3.1) 1.62 ± 0.03 (1.6)
Median (μm) 0.75 ± 0.02 0.97 ± 0.03 1.24 ± 0.03 1.55 ± 0.04
Mode (μm) 0.72 ± 0.03 0.93 ± 0.03 1.24 ± 0.04 1.66 ± 0.03
GSD 1.29 ± 0.02 (1.6) 1.36 ± 0.02 (1.3) 1.39 ± 0.02 (1.6) 1.36 ± 0.02 (1.7)
a Exact volume ﬂow rates for the indicated scale values are speciﬁed by TSI. A value of 1 refers to the according valve being completely closed, a value of 8 corresponds to roughly 3.6 L/min.
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interrupted), the APS data therefore describe the same aerosol ﬂows as
the CFP data. The aerosols trapped on CFPs were eluted from the ﬁlters
by incubation in 10 mL Dulbecco's phosphate-buffered saline (PBS)
(Sigma-Aldrich) at room temperature in the dark on a horizontal shaker
for 30 min. To increase the ﬂuorescent activity of DSF, the pH of the PBS
was adjusted to 9 (Kesavan, 2000).
2.3. DSF retrieval from CFPs and interaction with glycerol
The reliable calculation of the aerosol mass delivery in an aerosol ex-
posure system depends on exact values for the DSF- and aerosol mass
ﬂow rate and the DSF/aerosol mass ratio, which in turn depends on
quantitative elution of DSF from CFPs, i.e., on the absence of signiﬁcant
adsorption of DSF to the CFPs or any interaction between the CFPs and
the DSF ﬂuorescence. Since the DSF/aerosol mass ratios are different
for different aerosols, the absence of effects of glycerol on the ﬂuores-
cence of DSF in PBS also had to be conﬁrmed.
DSF recovery from CFPs was assessed by pipetting a 1:1 PBS (pH
9):glycerol solution containing 0.0002 g to 0.125 g of DSF onto CFPs,
followed by incubation in the dark until the added solution was fully
soaked into the ﬁlter. DSF was then eluted in 10 mL PBS (pH 9) for
30 min in the dark on a horizontal shaker and quantiﬁed and the re-
trieved DSF mass was compared with the applied DSF mass. Potential
effects of the presence of glycerol on the ﬂuorescence of DSF in PBS
were assessed bymeasuring the DSF ﬂuorescence in DSF dilution series
(8 × 10−7− 0.0002 g/L) in PBS (pH 9) containing 0.02, 0.2, 2, 20, and
200 g/L glycerol.
2.4. Test exposures in the VC24/48
Test exposures in the VC24/48 were conducted i) to conﬁrm aerosol
stability under applied conditions, i.e., the absence of relevant changes
in the aerosol size-distribution due to, for instance, hygroscopic growth,
particle size selective aerosol loss, or particle coalescence; ii) to test for
interactions between cell culture inserts and DSF, such as adsorption,
whichwould reduce the DSF recoverywhen collecting the PBS samples;
iii) to test for the possibility for accurate aerosol dosing, and iv) to deter-
mine the detection limits of the assay under experimentally relevant
conditions.
2.5. Experimental settings; CMAG and VC24/48
The interested reader can ﬁnd a detailed description of the VC24/48
on the manufacturer's website (www.vitrocell.com). Brieﬂy, the test
aerosol passes through the VC24/48 via the dilution system,which is lo-
cated on top of the exposuremodule. The exposure module provides 48exposure chambers, which are grouped into 8 rows of 6 replica posi-
tions. Upstream of each row, the aerosol in the dilution system can be
diluted with fresh air, resulting in a total of seven aerosol dilutions
(one per row) and a negative control exposed to fresh air only that
can be tested simultaneously. The aerosol passing the dilution system
is sampled by negative pressure into exposure trumpets, which project
downwards into the exposure chambers and generate a stagnation ﬂow
condition over the biological test system. Throughout all exposures de-
scribed here, the systemwas operated under identical settings as during
previous experiments for VC24/48 characterization (Majeed et al.,
2014), i.e. the whole system was kept at 37 °C, the dilution-air was
brought to 60± 5% relative humidity and the volume ﬂow rate through
the exposure trumpets was set to 2 mL for all positions. The dilution-air
volume ﬂow rates applied to different experiments are speciﬁed in the
section below.
2.6. Physical setup CMAG-VC24/48
To simulate exposures of organotypic cell cultures as routinely per-
formed at our facility, the aerosol volume ﬂow rate into the VC24/48
was adjusted to 0.41 L/min, corresponding to a 55mL puff from a tested
tobacco product (according to the Health Canada smoking regimen
(Health-Canada, 1999)) provided within 8 s.
A CFPhousing inwhich aerosols could be trapped on theirway to the
exposure system was installed in the tubings upstream of the VC24/48
(35 cm away from the entry point into the system). This permitted
the determination of the aerosol and DSF mass ﬂow rates, as described
in the section on aerosol characterization.
As the inﬂow of diluted air generates a positive pressure within the
VC24/48, a vacuum pump downstream of the system was required to
establish a constant unidirectional ﬂow. A bifurcation with a needle
valve at its open end was installed upstream of the pump. By placing a
mass ﬂow meter (0–5 L/min mass ﬂow meter, Aalborg, Orangeburg,
NY, USA) upstream the VC24/48, increasing or decreasing the ﬂow of
surrounding air through this needle valve allowed setting the volume
ﬂow rate entering the VC24/48 (with or without CFP upstream of the
system) to exactly 0.41 L/min. Once a stable inﬂow was reached, the
mass ﬂow meter was removed and aerosol trapping or aerosol expo-
sures commenced.
2.7. Aerosol stability
Aerosol stability in the VC 24/48 was conﬁrmed by feeding two of
the selected aerosols (0.8 and 1.1 μmmean diameter) through the com-
plete dilution system of the VC24/48. In two independent repetitions,
the particle number-size distributions were measured for 2–3 min, al-
ternately upstream and downstream of the system. A serial dilution
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rates from rows 1–7 being set to 0.1, 0.2, 0.5, 1, 1.5, 2, and 3 L/min,
resulting in aerosol concentrations of 81, 67, 45, 29, 22, 17, and 12%
comparedwith the CMAG output. Whenmeasuring aerosol parameters
downstream of the VC24/48, the APS served as a pump that generated
the constant unidirectional ﬂow through the system. Flow regulation
was achieved analogously to what is described above.2.8. DSF recovery from cell culture inserts
DSF recovery from cell culture inserts was assessed by placing
ThinCert™ cell culture inserts (24-well format, transparent insertmem-
brane, 0.4 μm pore diameter; Greiner Bio-One, Kremsmünster, Austria)
containing 100 μL PBS (pH 9) and 10–250 mg/L DSF in one row of the
exposuremodule; the insertswere exposed toﬁltered air, without feed-
ing aerosol into the system, for 28min (the durationwe apply in regular
exposures of organotypic cell cultures to aerosols generated by tobacco
products). PBS samples were then collected, the retrieved DSF concen-
tration was measured and compared with the applied concentration.
The ﬂow through the exposure chambers is independent of the ﬂow
regimen in the dilution system, therefore no speciﬁc dilution scheme
was applied; the dilution-air ﬂowwas set to 0.5 L/min in row onewith-
out any further input in subsequent rows.2.9. Aerosol dosing and sensitivity limits
To assess the dose response in aerosol delivery to cell culture inserts
and for identifying potential sensitivity limits, ThinCert™ cell culture in-
serts, each containing 100 μL PBS (pH 9), were placed into the exposure
module at speciﬁed positions. PBS samples served as surrogates for cell
cultures, providing an aqueous surface comparable to the mucus layer
present on organotypic cultures of airway epithelial cells.
To conﬁrm the linear increase in the aerosol deliverywith increasing
exposure duration, PBS samples present at positions 1–6 of rows 3 and 5
were exposed to aerosols for 3, 6, 9, 12, 15, 18, and 21 min. Only the
aerosol of 0.8 μm mean aerodynamic particle diameter was used, and
a dilution-air volume ﬂow rate of 1.5 L/min (resulting in an aerosol con-
centration of 22%) was applied at the inlet to the ﬁrst row of the VC24/
48 dilution system. To conﬁrm the reproducible aerosol generation, and
to calculate the aerosol mass delivery, aerosol was trapped on CFPs and
aerosol and DSF mass ﬂow rates and aerosol size measurements were
determined before the 3,15, 18 and 21 min exposure.
As during exposures of organotypic cell cultures in the VC24/48 the
dosing is usually not achieved by varying the exposure duration, but by
serially decreasing the applied aerosol concentration, dilution effects
were of greater interest than time-dependent dosing. Accordingly,
time-dependent dosing was only measured in one repetition and
more focus was put on dilution-dependent dosing. For dilution-depen-
dent dosing, 0.8 μmand 1.6 μmaerosols were used, with the cumulative
dilution-air volume ﬂow rates in rows 1–7 set to 0.1, 0.2, 0.5, 1, 1.5, 2,
and 3 L/min (81, 67, 45, 29, 22, 17, and 12% aerosols compared with
the CMAG output). Cell culture inserts containing PBS samples were
placed at positions 1–6 of rows 1–7 and exposed over 28 min. Aerosol
trapping on CFPs for the determination of aerosol and DSF mass ﬂow
rates and conﬁrmatory particle size measurement was performed
before, during, and after the exposures; i.e., the exposures were
interrupted after 14 min, mean aerodynamic particle size and GSD
were measured, aerosol samples were trapped on CFPs, and exposures
were then continued for another 14min. In total, four experimental rep-
etitions were performed.
In each case, loaded CFPs were washed in 10mL PBS (pH 9) at room
temperature for 30min in the dark on a horizontal shaker. PBS samples
retrieved from individual cell culture inserts were collected and stored
at 4 °C in the dark until further processing.2.10. Fluorescence measurements
Irrespective of the origin of the sample, ﬂuorescence measurements
were performed in the samemanner: 80 μL sample volumeswere pipet-
ted into individual wells of black 96-well microplates with a clear bot-
tom (ViewPlate-96, PerkinElmer, Waltham, MA, USA). Standard curves
for converting the ﬂuorescence readout to DSF concentrations (the
highly robust linear range covered 0.2 to 10−4mg/L, as determined em-
pirically)were generated on each plate using PBS (pH 9). Required sam-
ple dilutions were determined empirically.
Fluorometric measurements were performed in a FLUOstar Omega
Microplate Reader (BMG Labtech, Ortenberg, Germany) at an excitation
wavelength of 485 nm and an emission wavelength of 520 nm (top op-
tics reading, gain adjustment in the well containing the highest stan-
dard, fast reading mode). Blank correction for samples retrieved from
the VC24/48 was based on the ﬂuorescence of pure PBS (pH 9). For
the background correction when measuring DSF eluted from CFPs, PBS
(pH 9) in which an unloaded CFP was incubated for 30 min on a hori-
zontal shaker served as a blank.
2.11. Data processing
Primary readout for all samples was the DSF concentrations in the
collected PBS samples, which were converted to DSF masses based on
the known sample volumes. Using the time period duringwhich aerosol
was trapped on CFPs, DSF mass ﬂow rates were calculated according to
Eq. 1.
DSF mass flow rate ¼ measured DSF concentration eluate volume
trapping time:
ð1Þ
Using the aerosol mass ﬂow rate determined by weighting the
trapped aerosol, the DSF content of the aerosols was further calculated
(Eq. 2)
Mass ratio
DSF
aerosol
¼ DSF mass flow rate
aerosol mass flow rate
ð2Þ
Using the DSFmasses delivered to a given position within the VC24/
48, absolute aerosol mass deliveries were calculated according to Eq. 3.
Absolute aerosol mass delivery ¼ DSF mass detected at position XY
Mass ratio
DSF
Aerosol
ð3Þ
2.12. Statistical analysis
2.12.1. Control assessment
Linearity assessmentswere performed using the least squaresmeth-
od with constrained null y-intercept. The coefﬁcients of determination
(R2) are systematically reported as a goodness-of-ﬁt measurement.
2.12.2. Aerosol generation
Aerosol characterization was assessed using coefﬁcients of variation
(CV) considering independent repetitions of aerosol generation.
3. Results
3.1. Aerosol generation and characterization
Empirical testing of various CMAG settings resulted in a number of
aerosols that could be generated and kept stable over time. Four aero-
sols with mean aerodynamic particle sizes of 0.8, 1.1, 1.4, and 1.6 μm
were selected for further characterization and for test exposures in the
VC24/48. The CMAG settings, as well as relevant measured aerosol
Fig. 1. Particle number-size distributions of the aerosols generated in the condensation
monodisperse aerosol generator (CMAG). Error bars indicate standard deviations.
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of the selected aerosols are shown in Fig. 1. As shown in Fig. 2 and Table
1, the aerosols' number-size distributions were highly reproducible,
both within and between repeated runs of generation. However,
monodispersity of the aerosols was not reached, as GSDs were in the
range of 1.3–1.4, and considerable overlaps in the number-size distribu-
tions of the different aerosols were observed, which decreases the sen-
sitivity with which particle size-speciﬁc effects (e.g., the size-speciﬁc
aerosol delivery in exposure systems) can be detected. At least for
large differences in the mean aerodynamic particle size (roughly
500 nmand higher), thiswas still possible however, as a clear difference
in the delivery efﬁciency of the 0.8 μm and the 1.6 μm aerosols was de-
tectable (data not shown). Overall, aerosol and DSFmass ﬂow rates, and
accordingly DSF/aerosol mass ratios, were less reproducible than the
aerosol size parameters (Table 1). As expected, the aerosol mass ﬂow
rate increased strongly with increasing mean particle size, whereas
theDSFmassﬂow ratewas comparable for the 0.8, 1.1, and 1.4 μmaero-
sol (but lower for the 1.6 μm aerosol, because of the removal of DSF nu-
clei in the CMAG). Accordingly, the DSF/aerosol mass ratio decreased
strongly with increasing mean particle size.
3.2. DSF retrieval from CFPs and interaction with glycerol
Washing CFPs artiﬁcially loadedwith aerosol material in PBS consis-
tently resulted in a higher ﬂuorescence yield than expected based on
the DSF masses applied to the ﬁlters. As the only possible source of
the surplus ﬂuorescence was the ﬁlters themselves, separate blankFig. 2. In eight independent repetitions of aerosol generation, the aerosol mean aerodynamic p
Extracts of the measured data (ﬁve values reported by APS, each the average over ten seconds
aerosol size reproducibility across the repetitions.corrections for the CFPs were introduced: Unloaded CFPs were proc-
essed in parallelwith the loaded ones andwere included in all measure-
ments in later steps. Fig. 3A shows the DSF recovery from CFPs after
blank corrections. The mean of the ratio of measured to expected ﬂuo-
rescence yield over all data points was 1.069± 0.009, which conﬁrmed
quantitative DSF recovery from Cambridge ﬁlters over a broad range of
DSF concentrations.
At very high glycerol concentrations (200 g/L), an effect on the ﬂuo-
rescence of DSF in PBS could be detected, but this applied only to the
lower range of accessible DSF concentrations, i.e., below 1 μg/L (Fig.
3B). For 20 g/L glycerol, the effect was not observed. A deposition of
20 g aerosol but only 1 μg DSF per liter PBS was not reached under rel-
evant conditions, as evidenced by the aerosol mass deliveriesmeasured
in the VC24/48 (described below) and the measured DSF/aerosol mass
ratios (Table 1), glycerol effects were therefore considered irrelevant.
3.3. Test exposures in the VC24/48
3.3.1. DSF recovery from cell culture inserts
Over thewhole range of DSF concentrations assessed (10–250mg/L),
the results show a strong linear correlation between the expected
ﬂuorescence (added to cell culture inserts prior to exposure to fresh air
in the VC24/48) and the detected ﬂuorescence (measured upon expo-
sure to fresh air), but that a higher ﬂuorescent activity was retrieved
than added (Fig. 3C). The linear ﬁt shows a slope of 1.207 ± 0.026,
which is interpretable as the corrected average ratio of measured to ex-
pected ﬂuorescence retrieval over all data points. Exposure of pure PBS
did not result in any detectable ﬂuorescent signal, so the VC24/48 and
the cell culture inserts were ruled out as sources for the excess ﬂuores-
cence. The slight increase in the DSF concentrations of the PBS samples
was in fact expected, becausewhen exposed to air of 60% relative humid-
ity over 28min at 37 °C, evaporation of a small volume of water (but not
DSF) from the samples will occur. This effect introduces an over-estima-
tion of aerosol delivery, which, although not done in the present work,
could be corrected by determining the volume change in the PBS
samples.
3.3.2. Aerosol stability in the VC24/48
APS measurements up- and downstream the V24/48 revealed no
relevant changes in the particle size distributions (Fig. 3D), but a higher
particle concentration downstream the VC24/48 compared to upstream
the system. This was the result of the physical setup used for aerosol
sampling up- and downstream the VC24/48 not being identical, and
since in addition, the APS was operated at the upper limit of feasiblearticle diameters were continuously monitored with an aerodynamic particle sizer (APS).
acquisition time) are displayed to demonstrate the aerosol size stability over time and the
Fig. 3. Control experiments for testing disodium ﬂuorescein (DSF) retrieval and aerosol stability. A) DSF recovery from Cambridge ﬁlter pads (CFPs). Three independent measurements (2
for 1.25 and 0.05 g/L) were performed. The dotted line represents the linear ﬁt to the data. Its slope and R2 are indicated in the plot and demonstrate quantitative DSF retrieval. B) Effect of
glycerol on DSF ﬂuorescence. The ﬂuorescence of DSF at various concentrationswas tested in presence of 0 to 200 g/L glycerol. An effect was only detected at the lowest DSF concentration
in the presence of the highest glycerol concentration. C) DSF retrieval from cell culture inserts after exposure to ﬁltered humidiﬁed air in the Vitrocell® 24/48 aerosol exposure system
(VC24/48). Per tested DSF concentration, three samples were exposed simultaneously in a single repetition. The dotted line represents the linear ﬁt to the data; its slope and R2 are
indicated in the plot. The retrieved ﬂuorescence was slightly higher than expected, which is assumed to be a result of evaporation of water from the phosphate-buffered saline
samples in the inserts. D) Particle number-size distributions of two of the used aerosols, measured up- and downstream of the VC24/48 using an aerodynamic particle sizer (APS). No
change in the aerosol size was detected.
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the particle concentrations, but does not affect the reported size distri-
bution) represents an artifact of the applied experimental settings.
3.3.3. Aerosol dosing in the VC24/48
Decreasing the exposure duration, as well as decreasing the aerosol
concentration, resulted in decreased aerosol mass delivery to the ex-
posed PBS samples (Figs. 4 and 5). Twenty-one minutes of exposureFig. 4. Aerosol mass delivery to cell culture inserts as a function of exposure time. Time-
dependent dosing was only assessed for the aerosol of 0.8 μm mean aerodynamic
diameter at a dilution-air volume ﬂow rate of 1.5 L/min (22% aerosol) in a single
experimental repetition. The points represent the mean aerosol mass delivered per
position of two dilution rows (phosphate buffered saline samples retrieved from 12
replica positions were pooled). The dashed line represents the linear ﬁt to the data.resulted in 8.6 μg, and 3min of exposure resulted in 1.4 μg aerosol deliv-
ery per cell culture insert (both measured in pooled PBS samples re-
trieved from the 12 inserts exposed in rows 3 and 5). Linear
regression gave an R2 value of 0.95. For the 0.8 μm aerosol and 1.6 μm
aerosol, exposure to 82% aerosol over 28 min resulted in 97.0 ±
39.0 μg and 386.0 ± 76.0 μg aerosol delivered per cell culture insert.
The corresponding values measured for 12% aerosol are 15.4 ± 3.7 μg
and 57.8 ± 10.7 μg (each an average of six positions per row over
three repetitions). The R2 values for a linear relationship between aero-
sol concentration and delivery were 0.97 (0.8 μm aerosol) and 0.96
(1.6 μm aerosol).
3.3.4. Assay sensitivity, detection limits
The linear range of the DSF standard curves, deﬁning the lower and
upper limit of quantiﬁcation (LLOQ, ULOQ) covered the DSF concentra-
tion range from 200 down to 0.1 μg/L. At 0.1 μg/L, raw ﬂuorescence in-
tensity readouts ranged from 480 to 580, and PBS blanks yielded
values ranging from 270 to 360. The noise originating from the micro-
plates and/or the ﬂuorometer (i.e. readout from empty wells) was in
the range of 50.
As expected, with 1.4 μg per position, the lowest aerosol mass deliv-
ery was measured at 3 min of exposure to 22% aerosol (0.8 μm mean
aerodynamic diameter). In this particular case, the DSF/aerosol mass
ratio was 0.0053, and the DSF concentration in the 100 μL PBS samples
was 0.075 μg/L and therefore below the limits of quantiﬁcation. All
other measured DSF concentrations, however, were within the linear
range of the standard. For instance, a 6-min exposure to 22% aerosol
(0.8 μm) resulted in DSF concentrations of 0.143 μg/L. Exposure to 12%
aerosol of the lowest DSF content (1.6 μmmean aerodynamic diameter,
Fig. 5. Aerosol mass delivery as a function of aerosol concentration. Two aerosols, 0.8 μm
and 1.6 μm in mean aerodynamic diameter, were used for exposing phosphate-buffered
saline samples in cell culture inserts in the Vitrocell® 24/48 aerosol exposure system.
Serial aerosol dilution was achieved by applying cumulative dilution-air ﬂow rates of
0.1, 0.2, 0.5, 1, 1.5, 2, and 3 L/min in dilution rows 1–7 (corresponding to 81, 67, 45, 29,
22, 17, and 12% aerosol relative to the condensation monodisperse aerosol generator
output). Error bars indicate standard deviations; N= 4. The dashed lines represents the
linear ﬁt to the data (R2 values are indicated).
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aerosol mass delivery of 57.8 ± 10.7 μg per position, and a DSF concen-
tration of 400 μg/L – 4000-fold higher than the LLOQ.
4. Discussion
A variety of methods for characterizing the deposition of aerosols in
exposure systems have been developed and applied over the years
(Panas et al., 2014; Thorne & Adamson, 2013; Fujitani et al., 2015;
Ishikawa et al., 2016; Majeed et al., 2014; Kim et al., 2013; Scian et al.,
2009; Tippe et al., 2002; Wiegand et al., 2015; Fröhlich et al., 2013;
Mertes et al., 2013; Lízal et al., 2010; Lizal et al., 2012; Bowes & Swift,
1989; Belka et al., 2014), and all of them provide valuable tools for ex-
posure system characterization and in vitro dosimetry. The assay intro-
duced here is in many aspects comparable to existing ﬂuorescence-
based methods (Lízal et al., 2010; Lizal et al., 2012; Bowes & Swift,
1989; Belka et al., 2014), but the combination of ﬂuorometric aerosol
detection with liquid, water-soluble aerosols that can be generated in
a particle size-speciﬁc manner offers new possibilities: Particle size-
speciﬁc aerosol deposition covering a wide range of sizes has so far
mainly been investigated using solid particles, which in many aspects
are not fully representative of liquid aerosols (Koehler et al., 2012;
Marple et al., 1991; Lízal et al., 2010; Mullins et al., 2003). In addition,
the possibility to generate easily traceable aerosols of tunable particle
size distribution allows modeling a variety of aerosols of interest and
therefore studying their dynamics in an efﬁcient and unbiasedmanner.
In addition, because of the high water solubility of DSF and glycerol, de-
posited aerosol can quantitatively be washed off any internal systemparts using aqueous solvents. This could be exploited for quantifying
aerosol losses within an aerosol exposure system and, in combination
with the virtual non-toxicity of glycerol and DSF (Yannuzzi et al.,
1986), allows minimizing the risk of introducing system memory ef-
fects that might inﬂuence biological responses in later exposure
experiments.
The key prerequisites for a method for characterizing an aerosol ex-
posure system are: i) the robustness and sensitivity with which the de-
livered model aerosol can be quantiﬁed, ii) the robustness with which
the model aerosol can be generated and delivered to the exposure sys-
tem, and iii) the degree to which the model aerosol is representative of
aerosols to be tested in real-life experiments. Provided that these re-
quirements are fully met, simulating and quantifying potential biases
resulting from the exposure system is feasible, and identifying optimal
system operation conditions under which a minimal system-related
bias to the exposures can be achieved is possible.
The high sensitivity of ﬂuorometric DSF quantiﬁcation was demon-
strated in the test exposures in the VC24/48, as the DSF concentrations
measured in exposed PBS sampleswere commonly orders ofmagnitude
higher than required for accurate quantiﬁcation. Sensitivity issues arise
only if exposure durations are kept very short, and mainly if highly di-
luted aerosols are used. Furthermore, possible sources of bias, such as
the potential interference of glycerol with the ﬂuorescence of DSF or
the interaction of DSF with either CFPs or cell culture inserts, have
been tested and found not to affect the results. Although the method
may overestimate the aerosol mass delivery slightly, likely because of
water evaporation from the test samples, this effect can be eliminated
by correcting for the samples' volume change. Since, in addition, the
composition and the pH of PBS is stable, and because DSF is a robust
ﬂuorophore of relatively weak light sensitivity (Kesavan & Doherty,
2000; Weidner et al., 2011), the ﬂuorometric quantiﬁcation of aerosol
deposition can be considered unbiased by environmental effects.
The robustness of the aerosol generation with respect to the particle
number-size distribution and the mean particle diameters and their
GSDs was conﬁrmed, both over time within individual runs and be-
tween individual runs of aerosol generation.
Larger variations were observed for the aerosol and DSF mass ﬂow
rates, and hence for the DSF content of the aerosols. Differential ﬁltration
efﬁciencies of individual CFPs and ﬂuctuations in the CMAG output can-
not be ruled out by implication as causes for these variations. A salt con-
centration of 0.5% in the atomizer is beyondwhat is recommended by the
manufacturer, and could be a reason for the observed variations, hence
decreasing the DSF concentration could potentially increase the repro-
ducibility of the DSF mass ﬂow rate, which will be further pursued.
Given that the delivered aerosolmasseswere orders ofmagnitude higher
than required for quantitative detection, a more than tenfold decrease in
the salt concentration in the atomizer would be fully applicable.
Notably, the variations are unlikely to affect reproducibility of test
exposures by changing basic aerosol dynamics. Aerosol concentration
(that is, themass ﬂow rate) did not differ bymore than 20% between in-
dividual repetitions of aerosol generation and variations in the DSF con-
tent of the aerosols are not expected to have a detectable effect, as the
aerosol dynamics are determined by glycerol, which even for the aero-
sol of highest DSF content accounted for more than 99% of the particle
mass. Furthermore, aerosol and DSF mass ﬂow rates, as well as the
DSF/aerosol mass ratios, are required for correcting the measured DSF
delivery within the exposure system and for converting ﬂuorescence
measurements to delivery efﬁciencies and absolute mass deliveries.
Variations in the DSF and aerosol mass ﬂow rates and the DSF/aerosol
mass ratio are therefore corrected automatically. However, it is evident
that for reliable calculation of delivery efﬁciencies and absolute mass
deliveries, aerosol characterization has to be performed during each
test exposure, preferably at a higher frequency than it was done in
this work.
The test exposures in the VC24/48 demonstrated that the generated
glycerol aerosols provide a feasible model for simulating exposure
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number-size distributions were stable along their passage through the
system and the application of different aerosol concentrations was
reﬂected in differential aerosol deliveries. Moreover, even though not
investigated in detail, we observed different aerosol delivery efﬁciencies
for the 0.8 μm and the 1.6 μm aerosol in the test exposures with serial
aerosol dilution,which can only be interpreted as the result of the differ-
ent particle sizes. Although the cause of the lower delivery efﬁciency of
larger aerosols could not be derived from the current, limited data set,
the fact that it could be observed strongly indicates that with the meth-
od presented here, mechanistic properties of aerosol exposure systems
can be detected with high sensitivity.
Whether the last criterion listed above—the degree to which the
model aerosol is representative of the aerosols to be tested in exposure
experiments—is fulﬁlled, cannot be determined solely from the results
presented here.
In general, the complete absence of a traceable GVP in the DSF-la-
beled glycerol aerosols is advantageous if the dynamics of the particu-
late fraction are of interest; i.e., if a mechanistic understanding of the
particle delivery behavior of an exposure system is attempted. It clearly
limits, however, the suitability of themethod for modeling the total de-
livery of an aerosol containing relevant amounts of volatile and/or semi-
volatile compounds. Our focus was the simulation of liquid aerosols,
such as the ones generated by e-cigarettes (Hajek et al., 2014), which
are rich in glycerol and very poor in GVP constituents (Schripp et al.,
2013; Goniewicz et al., 2014). With regard to the toxicological assess-
ment of e-cigarettes, DSF-labeled glycerol aerosols therefore provide a
suitable model system for both, describing particle dynamics within
the exposure system as well as the overall aerosol delivery.
Given the advantages and theperformanceof themethod asdescribed
above, it potentially also provides an optimal approach for studying the
delivery of other types of liquid particles within an exposure system
and the system's mechanistic properties, however: The aerosols generat-
ed by e-cigarettes are comparable to the aerosols generated by various
medical inhalation devices (Watts et al., 2008; Patton & Byron, 2007;
Haghi et al., 2014), and ﬂuorometric methods are also applicable in phys-
ical models of the human respiratory tract (Lízal et al., 2010; Lizal et al.,
2012; Belka et al., 2014), or even of the human oral airways (Bowes &
Swift, 1989). Nonetheless, for other aerosol types, feasibility would have
to be determined individually. For any application, we recommend that
the delivery of the test aerosol is determined experimentally for a few
basic settings of the exposure system, and compared with the delivery
of the model aerosol used for test exposures. If the comparison meets
pre-deﬁned acceptance criteria, the model aerosols can be used to simu-
late any exposure system setting of interest.
In summary, we have developed an approach for aerosol exposure
system characterization that offers a method for investigating particle
dynamics within exposure systems in a particle size speciﬁc manner.
Its applicability, robustness, and sensitivity have been conﬁrmed
under realistic exposure conditions, using the Vitrocell® 24/48 aerosol
exposure system as a test system.
Themodel aerosolswe used are of low complexity and high stability,
and can therefore be characterized in detail. They offer the possibility of
investigating mechanistic properties of aerosol exposure systems with-
out interference fromdynamic changes in the aerosols. Although specif-
ically designed for characterizing exposure systems for their use in the
toxicological assessment of e-cigarettes, the approach is not limited to
this application. Results obtained by this method are representative
for liquid, glycerol-rich aerosols, comparable to the ones generated by
various electronic tobacco products, but also by a large number of med-
ical devices for drug inhalation. The ﬂuorometric detection of aerosol
deposition represents a fast, cost-efﬁcient, and reliable analytical meth-
od that does not require extensive analytical equipment and is therefore
suitable for any research institution. Consequently, this method repre-
sents a valuable tool in a broadﬁeld of applications, ranging from the ex-
perimental conﬁrmation of computationally simulated particledynamics, over the characterization of in vitro aerosol exposure systems,
to the detailed description of aerosol delivery in test systems of high
complexity.
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